高级检索
当前位置: 首页 > 详情页

Hepatitis B Virus Infection Dampens CtIP Expression in Hepatoma Cell

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Puai Hosp, Dept Clin Lab, 473 HanZheng St, Wuhan 430033, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China [3]Huazhong Univ Sci & Technol, Puai Hosp, Dept Internal Med, Tongji Med Coll, Wuhan 430033, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol,Inst Liver Dis,Tongji Hosp,Tongji Med Coll,Wuhan 430030,Hubei,Peoples R China
出处:
ISSN:

关键词: CtIP double-strand break hepatitis B virus hepatocellular carcinoma phosphorylation

摘要:
Hepatitis B virus (HBV) infection is a leading cause for hepatocellular carcinoma (HCC). Dysregulation of DNA double-strand break (DSB) repair may explain the pathogenesis of HBV-related HCC. Tumor suppressor CtIP plays a critical role in DSB repair. The purpose of present study was to clarify whether HBV affects CtIP expression in DSB repair of hepatoma cell. HepG2.2.15 was selected as the HBV positive hepatoma cell line, while HepG2 as the HBV negative hepatoma cell line. The two cell lines were treated with bleomycin to induce DSB. Bleomycin treatment could result in DSB by.-H2AX detection. CtIP gene expression was significantly upregulated after DSB in both HepG2 and HepG2.2.15, while CtIP expression of HepG2.2.15 was higher than that observed in HepG2 before and after DSB. CtIP protein expression was the same pattern as its gene expression. Phosphorylated CtIP (p-CtIP, serine site) was even lower than detectable limit in both HepG2 and HepG2.2.15 before DSB. However, p-CtIP of HepG2.2.15 was significantly lower than that of HepG2 after DSB. These results suggest that HBV could interfere CtIP via enhancing its expression while dampening its phosphorylation, which may disrupt DSB repair pathways and implicate CtIP dysfunction in HBV-related HCC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2016]版:
Q3 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Puai Hosp, Dept Clin Lab, 473 HanZheng St, Wuhan 430033, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol, Tongji Med Coll, Puai Hosp, Dept Clin Lab, 473 HanZheng St, Wuhan 430033, Hubei, Peoples R China [2]Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)